Briefly, leukemia is a type of cancer that results in abnormal production of white blood cells in the body. The only successful treatment known for that is chemotherapy, keeping it under examination. However, recent medical development has witnessed the use of umbilical cord blood stem cell therapy for leukemia patients who do not cure with chemotherapy alone.
Understanding of leukemia
This disease is a cancer that occurs in the bone marrow, usually leading to a very weak immune system. Individuals affected by this disease often experience infection. In addition, rather abnormally produced white blood cells become disturbed bone marrow and prevent the production of other kinds of blood cells which further cause bleeding, contusion, and anemia.
How can umbilical cord blood stem cells be treated for leukemia?
Contract for umbilical cord blood stem cell transplant which controls a large amount of chemotherapy and radiation therapy according to circumstances in order to kill cancer cells contained in the patient's bone marrow and blood flow. New umbilical cord blood stem cells transplanted into the body gradually learn to become established in the bone marrow and mainly produce healthy blood cells. This treatment only applies to patients with serious leukemia cases.
Desired Story
In medical gloves, successful cases of umbilical cord blood stem cell transplantation that cured many chronic diseases are rising. Leukemia is one! Here is the description of Lucas Waterman, a physician at Washington University Medical School in St. Louis. Lewis induces hope and courage. Lukas was first detected in acute lymphoblastic leukemia (ALL) in 2003, then returned to about 70 drugs to cure this disease, and chose two bone marrow stem cell transplants to fight cancer.
His first stem cell transplant donor was his brother. Along with immunosuppressive drugs, this transplant appeared to be successful without complications. However, as cancer came back several years later, Lukas was hospitalized for a second stem cell transplant from a donor, not from a family tree. This transplant worked for him too, but he attracted another chronic illness known as graft versus host disease (GVHD). This means that stem cell transplantation that actually cured him was currently violently attacking his body. Sometimes GVHD is a natural offshoot of bone marrow transplantation.
In GVHD, transplanted immune cells, called T cells, begin to proliferate and attack the tissues and cells of the body. It seems to be a foreign invader. In nearly 50% of bone marrow stem cell transplantation, GVHD is a development that may adversely affect the liver, skin, intestines, mouth and eyes.
But there is hope for this! Promising stem cell therapy named Prochymal, developed by Dr. Randy Mills, former CIRM President and CEO , Osiris Therapeutics is known to cure extreme cases of this disease. Currently, this treatment is in use and has been experienced in Phase 3 trials of infants and adults in the United States.
However, individuals such as Lucas Wurtman attract GVHD and is a true inspiration for those suffering from leukemia. He is also the reason most medical researchers are practicing to reach advanced treatment for this disease. Doctors do not want patients suffering from leukemia or GVHD to suffer quietly over a long period of time. The description of Lukas Wartman is to inform the medical field that there is immunity in the area of stem cell bone marrow transplantation to ensure that the malignant side effects are suppressed and the patient need not worry one treatment To have another illness to do.
